TY - JOUR AU - Nabel, G. J. PY - 2013 DA - 2013// TI - Designing tomorrow’s vaccines JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMra1204186 DO - 10.1056/NEJMra1204186 ID - Nabel2013 ER - TY - JOUR AU - Plotkin, S. A. PY - 2008 DA - 2008// TI - Vaccines: correlates of vaccine-induced immunity JO - Clin Infect Dis VL - 47 UR - https://doi.org/10.1086/589862 DO - 10.1086/589862 ID - Plotkin2008 ER - TY - JOUR AU - Xing, Z. AU - McFarland, C. T. AU - Sallenave, J. M. AU - Izzo, A. AU - Wang, J. AU - McMurray, D. N. PY - 2009 DA - 2009// TI - Intranasal mucosal boosting with an adenovirus-vectored vaccine markedly enhances the protection of BCG-primed guinea pigs against pulmonary tuberculosis JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0005856 DO - 10.1371/journal.pone.0005856 ID - Xing2009 ER - TY - JOUR AU - Hansen, S. G. AU - Ford, J. C. AU - Lewis, M. S. AU - Ventura, A. B. AU - Hughes, C. M. AU - Coyne-Johnson, L. PY - 2011 DA - 2011// TI - Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine JO - Nature VL - 473 UR - https://doi.org/10.1038/nature10003 DO - 10.1038/nature10003 ID - Hansen2011 ER - TY - JOUR AU - Chuang, I. AU - Sedegah, M. AU - Cicatelli, S. AU - Spring, M. AU - Polhemus, M. AU - Tamminga, C. PY - 2013 DA - 2013// TI - DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0055571 DO - 10.1371/journal.pone.0055571 ID - Chuang2013 ER - TY - JOUR AU - Ewer, K. J. AU - O’Hara, G. A. AU - Duncan, C. J. AU - Collins, K. A. AU - Sheehy, S. H. AU - Reyes-Sandoval, A. PY - 2013 DA - 2013// TI - Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation JO - Nat Commun VL - 4 UR - https://doi.org/10.1038/ncomms3836 DO - 10.1038/ncomms3836 ID - Ewer2013 ER - TY - JOUR AU - Sedegah, M. AU - Hollingdale, M. R. AU - Farooq, F. AU - Ganeshan, H. AU - Belmonte, M. AU - Kim, Y. PY - 2014 DA - 2014// TI - Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+ T cells targeting AMA1 class I epitopes JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0106241 DO - 10.1371/journal.pone.0106241 ID - Sedegah2014 ER - TY - JOUR AU - Bijker, E. M. AU - Teirlinck, A. C. AU - Schats, R. AU - Gemert, G. J. AU - Vegte-Bolmer, M. AU - Lieshout, L. PY - 2014 DA - 2014// TI - Cytotoxic markers associate with protection against malaria in human volunteers immunized with Plasmodium falciparum sporozoites JO - J Infect Dis VL - 210 UR - https://doi.org/10.1093/infdis/jiu293 DO - 10.1093/infdis/jiu293 ID - Bijker2014 ER - TY - JOUR AU - Seder, R. A. AU - Chang, L. J. AU - Enama, M. E. AU - Zephir, K. L. AU - Sarwar, U. N. AU - Gordon, I. J. PY - 2013 DA - 2013// TI - Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine JO - Science VL - 341 UR - https://doi.org/10.1126/science.1241800 DO - 10.1126/science.1241800 ID - Seder2013 ER - TY - JOUR AU - Casimiro, D. R. AU - Chen, L. AU - Fu, T. M. AU - Evans, R. K. AU - Caulfield, M. J. AU - Davies, M. E. PY - 2003 DA - 2003// TI - Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene JO - J Virol VL - 77 UR - https://doi.org/10.1128/JVI.77.11.6305-6313.2003 DO - 10.1128/JVI.77.11.6305-6313.2003 ID - Casimiro2003 ER - TY - JOUR AU - Weiss, W. R. AU - Good, M. F. AU - Hollingdale, M. R. AU - Miller, L. H. AU - Berzofsky, J. A. PY - 1989 DA - 1989// TI - Genetic control of immunity to Plasmodium yoelii sporozoites JO - J Immunol. VL - 143 ID - Weiss1989 ER - TY - JOUR AU - Hoffman, S. L. AU - Weiss, W. AU - Mellouk, S. AU - Sedegah, M. PY - 1990 DA - 1990// TI - Irradiated sporozoite vaccine induces cytotoxic T lymphocytes that recognize malaria antigens on the surface of infected hepatocytes JO - Immunol Lett VL - 25 UR - https://doi.org/10.1016/0165-2478(90)90087-7 DO - 10.1016/0165-2478(90)90087-7 ID - Hoffman1990 ER - TY - JOUR AU - Weiss, W. R. AU - Jiang, C. G. PY - 2012 DA - 2012// TI - Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0031247 DO - 10.1371/journal.pone.0031247 ID - Weiss2012 ER - TY - JOUR AU - Overstreet, M. G. AU - Cockburn, I. A. AU - Chen, Y. C. AU - Zavala, F. PY - 2008 DA - 2008// TI - Protective CD8+ T cells against Plasmodium liver stages: immunobiology of an ‘unnatural’ immune response JO - Immunol Rev VL - 225 UR - https://doi.org/10.1111/j.1600-065X.2008.00671.x DO - 10.1111/j.1600-065X.2008.00671.x ID - Overstreet2008 ER - TY - JOUR AU - Krzych, U. AU - Dalai, S. AU - Zarling, S. AU - Pichugin, A. PY - 2012 DA - 2012// TI - Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria JO - Front Immunol. VL - 3 UR - https://doi.org/10.3389/fimmu.2012.00370 DO - 10.3389/fimmu.2012.00370 ID - Krzych2012 ER - TY - JOUR AU - Rodrigues, E. G. AU - Zavala, F. AU - Eichinger, D. AU - Wilson, J. M. AU - Tsuji, M. PY - 1997 DA - 1997// TI - Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria JO - J Immunol. VL - 158 ID - Rodrigues1997 ER - TY - JOUR AU - Schofield, L. PY - 1989 DA - 1989// TI - T cell immunity to malaria sporozoites JO - Exp Parasitol VL - 68 UR - https://doi.org/10.1016/0014-4894(89)90118-5 DO - 10.1016/0014-4894(89)90118-5 ID - Schofield1989 ER - TY - JOUR AU - Weiss, W. R. AU - Sedegah, M. AU - Beaudoin, R. L. AU - Miller, L. H. AU - Good, M. F. PY - 1988 DA - 1988// TI - CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites JO - Proc Natl Acad Sci USA VL - 85 UR - https://doi.org/10.1073/pnas.85.2.573 DO - 10.1073/pnas.85.2.573 ID - Weiss1988 ER - TY - JOUR AU - Cockburn, I. A. AU - Amino, R. AU - Kelemen, R. K. AU - Kuo, S. C. AU - Tse, S. W. AU - Radtke, A. PY - 2013 DA - 2013// TI - In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages JO - Proc Natl Acad Sci USA VL - 110 UR - https://doi.org/10.1073/pnas.1303858110 DO - 10.1073/pnas.1303858110 ID - Cockburn2013 ER - TY - JOUR AU - Tsuji, M. PY - 2010 DA - 2010// TI - A retrospective evaluation of the role of T cells in the development of malaria vaccine JO - Exp Parasitol VL - 126 UR - https://doi.org/10.1016/j.exppara.2009.11.009 DO - 10.1016/j.exppara.2009.11.009 ID - Tsuji2010 ER - TY - JOUR AU - Gilbert, S. C. AU - Schneider, J. AU - Hannan, C. M. AU - Hu, J. T. AU - Plebanski, M. AU - Sinden, R. PY - 2002 DA - 2002// TI - Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes JO - Vaccine. VL - 20 UR - https://doi.org/10.1016/S0264-410X(01)00450-9 DO - 10.1016/S0264-410X(01)00450-9 ID - Gilbert2002 ER - TY - JOUR AU - Sedegah, M. AU - Trevor, J. AU - Kaur, M. AU - Hedstrom, R. AU - Hobart, P. AU - Tine, J. PY - 1998 DA - 1998// TI - Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine JO - Proc Natl Acad Sci USA VL - 95 UR - https://doi.org/10.1073/pnas.95.13.7648 DO - 10.1073/pnas.95.13.7648 ID - Sedegah1998 ER - TY - JOUR AU - Hill, A. V. AU - Reyes-Sandoval, A. AU - O’Hara, G. AU - Ewer, K. AU - Lawrie, A. AU - Goodman, A. PY - 2010 DA - 2010// TI - Prime-boost vectored malaria vaccines: progress and prospects JO - Hum Vaccin. VL - 6 UR - https://doi.org/10.4161/hv.6.1.10116 DO - 10.4161/hv.6.1.10116 ID - Hill2010 ER - TY - JOUR AU - Bruder, J. T. AU - Semenova, E. AU - Chen, P. AU - Limbach, K. AU - Patterson, N. B. AU - Stefaniak, M. E. PY - 2012 DA - 2012// TI - Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0033920 DO - 10.1371/journal.pone.0033920 ID - Bruder2012 ER - TY - JOUR AU - Jiang, G. AU - Shi, M. AU - Conteh, S. AU - Richie, N. AU - Banania, G. AU - Geneshan, H. PY - 2009 DA - 2009// TI - Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies JO - PLoS ONE VL - 4 UR - https://doi.org/10.1371/journal.pone.0006559 DO - 10.1371/journal.pone.0006559 ID - Jiang2009 ER - TY - JOUR AU - Moorthy, V. S. AU - Imoukhuede, E. B. AU - Milligan, P. AU - Bojang, K. AU - Keating, S. AU - Kaye, P. PY - 2004 DA - 2004// TI - A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults JO - PLoS Med. VL - 1 UR - https://doi.org/10.1371/journal.pmed.0010033 DO - 10.1371/journal.pmed.0010033 ID - Moorthy2004 ER - TY - JOUR AU - Bejon, P. AU - Mwacharo, J. AU - Kai, O. K. AU - Todryk, S. AU - Keating, S. AU - Lang, T. PY - 2006 DA - 2006// TI - Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1–6 year old children in a malaria endemic area JO - Vaccine. VL - 24 UR - https://doi.org/10.1016/j.vaccine.2006.03.029 DO - 10.1016/j.vaccine.2006.03.029 ID - Bejon2006 ER - TY - JOUR AU - Porter, D. W. AU - Thompson, F. M. AU - Berthoud, T. K. AU - Hutchings, C. L. AU - Andrews, L. AU - Biswas, S. PY - 2011 DA - 2011// TI - A human phase I/IIa malaria challenge trial of a polyprotein malaria vaccine JO - Vaccine. VL - 29 UR - https://doi.org/10.1016/j.vaccine.2011.03.083 DO - 10.1016/j.vaccine.2011.03.083 ID - Porter2011 ER - TY - JOUR AU - Sheehy, S. H. AU - Duncan, C. J. AU - Elias, S. C. AU - Biswas, S. AU - Collins, K. A. AU - O’Hara, G. A. PY - 2012 DA - 2012// TI - Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0031208 DO - 10.1371/journal.pone.0031208 ID - Sheehy2012 ER - TY - JOUR AU - Ogwang, C. AU - Afolabi, M. AU - Kimani, D. AU - Jagne, Y. J. AU - Sheehy, S. H. AU - Bliss, C. M. PY - 2013 DA - 2013// TI - Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0057726 DO - 10.1371/journal.pone.0057726 ID - Ogwang2013 ER - TY - JOUR AU - Webster, D. P. AU - Dunachie, S. AU - Vuola, J. M. AU - Berthoud, T. AU - Keating, S. AU - Laidlaw, S. M. PY - 2005 DA - 2005// TI - Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara JO - Proc Natl Acad Sci USA VL - 102 UR - https://doi.org/10.1073/pnas.0406381102 DO - 10.1073/pnas.0406381102 ID - Webster2005 ER - TY - JOUR AU - Tamminga, C. PY - 2011 DA - 2011// TI - Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0025868 DO - 10.1371/journal.pone.0025868 ID - Tamminga2011 ER - TY - STD TI - WHO. Preferred product characteristics for malaria vaccines. 2014. Accessed at http://www.who.int/immunization/documents/innovation/WHO_IVB_14.09/en/. UR - http://www.who.int/immunization/documents/innovation/WHO_IVB_14.09/en/ ID - ref33 ER - TY - JOUR AU - Vogels, R. AU - Zuijdgeest, D. AU - Rijnsoever, R. AU - Hartkoorn, E. AU - Damen, I. AU - Bethune, M. P. PY - 2003 DA - 2003// TI - Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity JO - J Virol VL - 77 UR - https://doi.org/10.1128/JVI.77.15.8263-8271.2003 DO - 10.1128/JVI.77.15.8263-8271.2003 ID - Vogels2003 ER - TY - JOUR AU - Nwanegbo, E. AU - Vardas, E. AU - Gao, W. AU - Whittle, H. AU - Sun, H. AU - Rowe, D. PY - 2004 DA - 2004// TI - Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of the Gambia, South Africa, and the United States JO - Clin Diagn Lab Immunol VL - 11 ID - Nwanegbo2004 ER - TY - JOUR AU - Xiang, Z. AU - Li, Y. AU - Cun, A. AU - Yang, W. AU - Ellenberg, S. AU - Switzer, W. M. PY - 2006 DA - 2006// TI - Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa JO - Emerg Infect Dis VL - 12 UR - https://doi.org/10.3201/eid1210.060078 DO - 10.3201/eid1210.060078 ID - Xiang2006 ER - TY - JOUR AU - Barouch, D. H. AU - Kik, S. V. AU - Weverling, G. J. AU - Dilan, R. AU - King, S. L. AU - Maxfield, L. F. PY - 2011 DA - 2011// TI - International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations JO - Vaccine. VL - 29 UR - https://doi.org/10.1016/j.vaccine.2011.05.025 DO - 10.1016/j.vaccine.2011.05.025 ID - Barouch2011 ER - TY - JOUR AU - Johnson, T. R. AU - Rangel, D. AU - Graham, B. S. AU - Brough, D. E. AU - Gall, J. G. PY - 2014 DA - 2014// TI - Genetic vaccine for respiratory syncytial virus provides protection without disease potentiation JO - Mol Ther VL - 22 UR - https://doi.org/10.1038/mt.2013.142 DO - 10.1038/mt.2013.142 ID - Johnson2014 ER - TY - JOUR AU - Quinn, K. M. AU - Costa, A. AU - Yamamoto, A. AU - Berry, D. AU - Lindsay, R. W. AU - Darrah, P. A. PY - 2013 DA - 2013// TI - Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization JO - J Immunol. VL - 190 UR - https://doi.org/10.4049/jimmunol.1202861 DO - 10.4049/jimmunol.1202861 ID - Quinn2013 ER - TY - JOUR AU - Catanzaro, A. T. AU - Koup, R. A. AU - Roederer, M. AU - Bailer, R. T. AU - Enama, M. E. AU - Moodie, Z. PY - 2006 DA - 2006// TI - Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector JO - J Infect Dis VL - 194 UR - https://doi.org/10.1086/509258 DO - 10.1086/509258 ID - Catanzaro2006 ER - TY - JOUR AU - McElrath, M. J. AU - Rosa, S. C. AU - Moodie, Z. AU - Dubey, S. AU - Kierstead, L. AU - Janes, H. PY - 2008 DA - 2008// TI - HIV-1 vaccine-induced immunity in the test-of-concept step study: a case–cohort analysis JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61592-5 DO - 10.1016/S0140-6736(08)61592-5 ID - McElrath2008 ER - TY - JOUR AU - Zak, D. E. AU - Andersen-Nissen, E. AU - Peterson, E. R. AU - Sato, A. AU - Hamilton, M. K. AU - Borgerding, J. PY - 2012 DA - 2012// TI - Merck Ad5/HIV induces broad innate immune activation that predicts CD8(+) T-cell responses but is attenuated by preexisting Ad5 immunity JO - Proc Natl Acad Sci USA VL - 109 UR - https://doi.org/10.1073/pnas.1208972109 DO - 10.1073/pnas.1208972109 ID - Zak2012 ER - TY - JOUR AU - Abbink, P. AU - Lemckert, A. A. AU - Ewald, B. A. AU - Lynch, D. M. AU - Denholtz, M. AU - Smits, S. PY - 2007 DA - 2007// TI - Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D JO - J Virol VL - 81 UR - https://doi.org/10.1128/JVI.02696-06 DO - 10.1128/JVI.02696-06 ID - Abbink2007 ER - TY - JOUR AU - Geisbert, T. W. AU - Bailey, M. AU - Hensley, L. AU - Asiedu, C. AU - Geisbert, J. AU - Stanley, D. PY - 2011 DA - 2011// TI - Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge JO - J Virol VL - 85 UR - https://doi.org/10.1128/JVI.02407-10 DO - 10.1128/JVI.02407-10 ID - Geisbert2011 ER - TY - JOUR AU - Colloca, S. AU - Barnes, E. AU - Folgori, A. AU - Ammendola, V. AU - Capone, S. AU - Cirillo, A. PY - 2012 DA - 2012// TI - Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species JO - Sci Transl Med VL - 4 UR - https://doi.org/10.1126/scitranslmed.3002925 DO - 10.1126/scitranslmed.3002925 ID - Colloca2012 ER - TY - JOUR AU - Stanley, D. A. AU - Honko, A. N. AU - Asiedu, C. AU - Trefry, J. C. AU - Lau-Kilby, A. W. AU - Johnson, J. C. PY - 2014 DA - 2014// TI - Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge JO - Nat Med VL - 20 ID - Stanley2014 ER - TY - JOUR AU - McVey, D. AU - Cranfield, M. R. AU - Torano, H. AU - Kuete, H. M. AU - Lee, G. P. AU - Glenn, A. PY - 2013 DA - 2013// TI - Adenoviruses isolated from wild gorillas are closely related to human species C viruses JO - Virology VL - 444 UR - https://doi.org/10.1016/j.virol.2013.05.041 DO - 10.1016/j.virol.2013.05.041 ID - McVey2013 ER - TY - JOUR AU - Sedegah, M. AU - Brice, G. T. AU - Rogers, W. O. AU - Doolan, D. L. AU - Charoenvit, Y. AU - Jones, T. R. PY - 2002 DA - 2002// TI - Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations JO - Infect Immun VL - 70 UR - https://doi.org/10.1128/IAI.70.7.3493-3499.2002 DO - 10.1128/IAI.70.7.3493-3499.2002 ID - Sedegah2002 ER - TY - JOUR AU - Brough, D. E. AU - Lizonova, A. AU - Hsu, C. AU - Kulesa, V. A. AU - Kovesdi, I. PY - 1996 DA - 1996// TI - A gene transfer vector–cell line system for complete functional complementation of adenovirus early regions E1 and E4 JO - J Virol VL - 70 ID - Brough1996 ER - TY - JOUR AU - Dobano, C. AU - McTague, A. AU - Sette, A. AU - Hoffman, S. L. AU - Rogers, W. O. AU - Doolan, D. L. PY - 2007 DA - 2007// TI - Mutating the anchor residues associated with MHC binding inhibits and deviates CD8+ T cell mediated protective immunity against malaria JO - Mol Immunol VL - 44 UR - https://doi.org/10.1016/j.molimm.2006.11.003 DO - 10.1016/j.molimm.2006.11.003 ID - Dobano2007 ER - TY - JOUR AU - Charoenvit, Y. AU - Leef, M. F. AU - Yuan, L. F. AU - Sedegah, M. AU - Beaudoin, R. L. PY - 1987 DA - 1987// TI - Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens JO - Infect Immun. VL - 55 ID - Charoenvit1987 ER - TY - STD TI - WHO. World Malaria Report Geneva: World Health Organization. 2016; http://www.who.int/malaria/publications/world-malaria-report-2016/report/en/. UR - http://www.who.int/malaria/publications/world-malaria-report-2016/report/en/. ID - ref52 ER - TY - JOUR AU - Agnandji, S. T. AU - Lell, B. AU - Soulanoudjingar, S. S. AU - Fernandes, J. F. AU - Abossolo, B. P. AU - Conzelmann, C. PY - 2011 DA - 2011// TI - First results of phase 3 trial of RTS, S/AS01 malaria vaccine in African children JO - N Engl J Med. VL - 365 UR - https://doi.org/10.1056/NEJMoa1102287 DO - 10.1056/NEJMoa1102287 ID - Agnandji2011 ER - TY - JOUR AU - Agnandji, S. T. AU - Lell, B. AU - Fernandes, J. F. AU - Abossolo, B. P. AU - Methogo, B. G. PY - 2012 DA - 2012// TI - A phase 3 trial of RTS, S/AS01 malaria vaccine in African infants JO - N Engl J Med. VL - 367 UR - https://doi.org/10.1056/NEJMoa1208394 DO - 10.1056/NEJMoa1208394 ID - Agnandji2012 ER - TY - JOUR AU - Olotu, A. AU - Fegan, G. AU - Wambua, J. AU - Nyangweso, G. AU - Awuondo, K. O. AU - Leach, A. PY - 2013 DA - 2013// TI - Four-year efficacy of RTS, S/AS01E and its interaction with malaria exposure JO - N Engl J Med. VL - 368 UR - https://doi.org/10.1056/NEJMoa1207564 DO - 10.1056/NEJMoa1207564 ID - Olotu2013 ER - TY - STD TI - WHO. Malaria vaccine: WHO position paper. 2016. http://www.who.int/wer/2016/wer9104/en/. UR - http://www.who.int/wer/2016/wer9104/en/ ID - ref56 ER - TY - JOUR AU - Hodgson, S. H. AU - Ewer, K. J. AU - Bliss, C. M. AU - Edwards, N. J. AU - Rampling, T. AU - Anagnostou, N. A. PY - 2014 DA - 2014// TI - Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals JO - J Infect Dis. VL - 7 ID - Hodgson2014 ER - TY - JOUR AU - Ogwang, C. AU - Kimani, D. AU - Edwards, N. J. AU - Roberts, R. AU - Mwacharo, J. AU - Bowyer, G. PY - 2015 DA - 2015// TI - Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults JO - Sci Transl Med. VL - 7 UR - https://doi.org/10.1126/scitranslmed.aaa2373 DO - 10.1126/scitranslmed.aaa2373 ID - Ogwang2015 ER - TY - JOUR AU - Sullivan, N. J. AU - Hensley, L. AU - Asiedu, C. AU - Geisbert, T. W. AU - Stanley, D. AU - Johnson, J. PY - 2011 DA - 2011// TI - CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates JO - Nat Med. VL - 17 UR - https://doi.org/10.1038/nm.2447 DO - 10.1038/nm.2447 ID - Sullivan2011 ER - TY - JOUR AU - Barnes, E. AU - Folgori, A. AU - Capone, S. AU - Swadling, L. AU - Aston, S. AU - Kurioka, A. PY - 2012 DA - 2012// TI - Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man JO - Sci Transl Med. VL - 4 UR - https://doi.org/10.1126/scitranslmed.3003155 DO - 10.1126/scitranslmed.3003155 ID - Barnes2012 ER - TY - JOUR AU - Swadling, L. AU - Capone, S. AU - Antrobus, R. D. AU - Brown, A. AU - Richardson, R. AU - Newell, E. W. PY - 2014 DA - 2014// TI - A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory JO - Sci Transl Med VL - 6 UR - https://doi.org/10.1126/scitranslmed.3009185 DO - 10.1126/scitranslmed.3009185 ID - Swadling2014 ER - TY - JOUR AU - Ledgerwood, J. E. AU - DeZure, A. D. AU - Stanley, D. A. AU - Novik, L. AU - Enama, M. E. AU - Berkowitz, N. M. PY - 2017 DA - 2017// TI - Chimpanzee adenovirus vector ebola vaccine JO - N Engl J Med. VL - 376 UR - https://doi.org/10.1056/NEJMoa1410863 DO - 10.1056/NEJMoa1410863 ID - Ledgerwood2017 ER - TY - JOUR AU - Rampling, T. AU - Ewer, K. AU - Bowyer, G. AU - Wright, D. AU - Imoukhuede, E. B. AU - Payne, R. PY - 2015 DA - 2015// TI - A monovalent chimpanzee adenovirus ebola vaccine—preliminary report JO - N Engl J Med. ID - Rampling2015 ER - TY - JOUR AU - Limbach, K. AU - Aguiar, J. AU - Gowda, K. AU - Patterson, N. AU - Abot, E. AU - Sedegah, M. PY - 2011 DA - 2011// TI - Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates JO - Malar J. VL - 10 UR - https://doi.org/10.1186/1475-2875-10-65 DO - 10.1186/1475-2875-10-65 ID - Limbach2011 ER - TY - JOUR AU - Flingai, S. AU - Czerwonko, M. AU - Goodman, J. AU - Kudchodkar, S. B. AU - Muthumani, K. AU - Weiner, D. B. PY - 2013 DA - 2013// TI - Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants JO - Front Immunol. VL - 4 UR - https://doi.org/10.3389/fimmu.2013.00354 DO - 10.3389/fimmu.2013.00354 ID - Flingai2013 ER - TY - JOUR AU - Padte, N. N. AU - Boente-Carrera, M. AU - Andrews, C. D. AU - McManus, J. AU - Grasperge, B. F. AU - Gettie, A. PY - 2013 DA - 2013// TI - A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates JO - PLoS ONE. VL - 8 UR - https://doi.org/10.1371/journal.pone.0078407 DO - 10.1371/journal.pone.0078407 ID - Padte2013 ER -